Strategic partnership will link DNA data with rich clinical data to identify novel biomarkers for targeted cancer therapies The two companies will utilize AI and multimodal molecular data to unlock ...
Guardant Health has the first FDA-approved liquid biopsy that can spot colon cancer. Co-CEO Helmy Eltoukhy tells Business Insider the story of how they used Silicon Valley strategy to build it. This ...
At first, cancer is a quiet disease. Inside the body, cells are aggressively multiplying out of control, changing everything. But on the outside, there's nothing special to see or feel. Not yet. For ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results